Sharad Agarwal

Sharad Agarwal currently serves as the Head of Large Molecule Development in Regulatory Affairs CMC at EMD Serono, Inc., a position held since July 2021. Prior experience includes roles as Director of Regulatory Affairs at Mallinckrodt Pharmaceuticals from October 2016 to July 2021, and various CMC Regulatory Affairs positions at Valeant Pharmaceuticals, Merck, and Pfizer between 2007 and 2016. Sharad Agarwal holds a degree in Molecular Biology and Biochemistry from Rutgers University, obtained from 2001 to 2005.